rs56219475

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BA1

This summary comes from the ClinGen Evidence Repository: The filtering allele frequency of the c.1964C>T (p.Pro655Leu) variant in the SOS1 gene is 1.153% (803/65674) of European chromosomes by the Exome Aggregation Consortium, which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert Panel (BA1; PMID:29493581) LINK:https://erepo.genome.network/evrepo/ui/classification/CA136088/MONDO:0021060/004

Frequency

Genomes: 𝑓 0.0076 ( 11 hom., cov: 32)
Exomes 𝑓: 0.0086 ( 74 hom. )

Consequence

SOS1
NM_005633.4 missense

Scores

3
15

Clinical Significance

Benign reviewed by expert panel B:19

Conservation

PhyloP100: 5.44

Publications

20 publications found
Variant links:
Genes affected
SOS1 (HGNC:11187): (SOS Ras/Rac guanine nucleotide exchange factor 1) This gene encodes a protein that is a guanine nucleotide exchange factor for RAS proteins, membrane proteins that bind guanine nucleotides and participate in signal transduction pathways. GTP binding activates and GTP hydrolysis inactivates RAS proteins. The product of this gene may regulate RAS proteins by facilitating the exchange of GTP for GDP. Mutations in this gene are associated with gingival fibromatosis 1 and Noonan syndrome type 4. [provided by RefSeq, Jul 2008]
SOS1 Gene-Disease associations (from GenCC):
  • Noonan syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Noonan syndrome 4
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Genomics England PanelApp, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • fibromatosis, gingival, 1
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • hereditary gingival fibromatosis
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • cardiofaciocutaneous syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
  • Costello syndrome
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BA1
For more information check the summary or visit ClinGen Evidence Repository.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SOS1NM_005633.4 linkc.1964C>T p.Pro655Leu missense_variant Exon 12 of 23 ENST00000402219.8 NP_005624.2 Q07889-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SOS1ENST00000402219.8 linkc.1964C>T p.Pro655Leu missense_variant Exon 12 of 23 1 NM_005633.4 ENSP00000384675.2 Q07889-1

Frequencies

GnomAD3 genomes
AF:
0.00762
AC:
1158
AN:
151948
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00266
Gnomad AMI
AF:
0.0921
Gnomad AMR
AF:
0.00466
Gnomad ASJ
AF:
0.00260
Gnomad EAS
AF:
0.000192
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.0133
Gnomad MID
AF:
0.00633
Gnomad NFE
AF:
0.0106
Gnomad OTH
AF:
0.00623
GnomAD2 exomes
AF:
0.00745
AC:
1861
AN:
249736
AF XY:
0.00756
show subpopulations
Gnomad AFR exome
AF:
0.00242
Gnomad AMR exome
AF:
0.00409
Gnomad ASJ exome
AF:
0.00498
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0121
Gnomad NFE exome
AF:
0.0116
Gnomad OTH exome
AF:
0.00593
GnomAD4 exome
AF:
0.00860
AC:
12493
AN:
1452776
Hom.:
74
Cov.:
28
AF XY:
0.00838
AC XY:
6061
AN XY:
723268
show subpopulations
African (AFR)
AF:
0.00231
AC:
77
AN:
33292
American (AMR)
AF:
0.00419
AC:
187
AN:
44646
Ashkenazi Jewish (ASJ)
AF:
0.00388
AC:
101
AN:
26024
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39562
South Asian (SAS)
AF:
0.000813
AC:
70
AN:
86060
European-Finnish (FIN)
AF:
0.0118
AC:
621
AN:
52776
Middle Eastern (MID)
AF:
0.00244
AC:
14
AN:
5748
European-Non Finnish (NFE)
AF:
0.00999
AC:
11032
AN:
1104642
Other (OTH)
AF:
0.00651
AC:
391
AN:
60026
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.451
Heterozygous variant carriers
0
528
1057
1585
2114
2642
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
394
788
1182
1576
1970
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00762
AC:
1158
AN:
152066
Hom.:
11
Cov.:
32
AF XY:
0.00767
AC XY:
570
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.00265
AC:
110
AN:
41496
American (AMR)
AF:
0.00465
AC:
71
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.00260
AC:
9
AN:
3464
East Asian (EAS)
AF:
0.000193
AC:
1
AN:
5188
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4816
European-Finnish (FIN)
AF:
0.0133
AC:
141
AN:
10576
Middle Eastern (MID)
AF:
0.00680
AC:
2
AN:
294
European-Non Finnish (NFE)
AF:
0.0106
AC:
722
AN:
67958
Other (OTH)
AF:
0.00617
AC:
13
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
64
128
191
255
319
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00972
Hom.:
29
Bravo
AF:
0.00730
TwinsUK
AF:
0.00836
AC:
31
ALSPAC
AF:
0.00882
AC:
34
ESP6500AA
AF:
0.00204
AC:
9
ESP6500EA
AF:
0.00977
AC:
84
ExAC
AF:
0.00782
AC:
949
Asia WGS
AF:
0.00145
AC:
5
AN:
3474
EpiCase
AF:
0.0106
EpiControl
AF:
0.0116

ClinVar

Significance: Benign
Submissions summary: Benign:19
Revision: reviewed by expert panel
LINK: link

Submissions by phenotype

not specified Benign:7
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 15, 2015
Greenwood Genetic Center Diagnostic Laboratories, Greenwood Genetic Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Oct 28, 2006
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 07, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Clinical Genetics, Academic Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, Amsterdam University Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:5
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 17143282, 20981092, 23487764, 17143285, 27153395, 32514133) -

-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 12, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

SOS1: BS1, BS2 -

RASopathy Benign:3
Apr 18, 2017
ClinGen RASopathy Variant Curation Expert Panel
Significance:Benign
Review Status:reviewed by expert panel
Collection Method:curation

The filtering allele frequency of the c.1964C>T (p.Pro655Leu) variant in the SOS1 gene is 1.153% (803/65674) of European chromosomes by the Exome Aggregation Consortium, which is a high enough frequency to be classified as benign based on thresholds defined by the ClinGen RASopathy Expert Panel (BA1; PMID:29493581) -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Baylor Genetics
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Variant classified using ACMG guidelines -

Arrhythmogenic right ventricular cardiomyopathy Benign:1
Feb 02, 2017
Center for Advanced Laboratory Medicine, UC San Diego Health, University of California San Diego
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Noonan syndrome 4 Benign:1
Apr 27, 2017
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to determine this variant is unlikely to cause disease. Therefore, this variant is classified as likely benign. -

Cardiovascular phenotype Benign:1
Aug 24, 2017
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Noonan syndrome and Noonan-related syndrome Benign:1
Apr 16, 2021
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.43
T
BayesDel_noAF
Benign
-0.38
CADD
Uncertain
24
DANN
Benign
0.79
DEOGEN2
Benign
0.36
T;T;T
Eigen
Benign
-0.026
Eigen_PC
Benign
0.21
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Uncertain
0.94
.;D;D
MetaRNN
Benign
0.0046
T;T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.6
L;L;.
PhyloP100
5.4
PrimateAI
Uncertain
0.70
T
PROVEAN
Benign
-1.7
N;N;N
REVEL
Benign
0.091
Sift
Benign
0.31
T;T;T
Sift4G
Benign
0.47
T;T;T
Polyphen
0.066
B;B;.
Vest4
0.28
MVP
0.32
MPC
0.59
ClinPred
0.021
T
GERP RS
5.8
Varity_R
0.34
gMVP
0.76
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs56219475; hg19: chr2-39241107; COSMIC: COSV107503036; API